Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells

Abstract This article reports a simple one-step method of attaching folic acid (FA) to gold nanoparticles (AuNPs) and its fine tuning using different polyethylene glycol (PEG) backbones. PEG backbones used in this study are PEG-diamine with molecular weights 2000 (PAM2-2K) and 10,000 (PAM2-10K), PEG-tetramine with molecular weight 20,000 (PAM4-20K), and PEG-dithiol with molecular weight 2000 (PSH2-2K). The nanoconjugates were characterized with ultraviolet-visible spectroscopy, transmission electron microscopy (TEM), thermogravimetric analysis, Fourier transform infrared spectroscopy, inductively coupled plasma analysis, and radioactivity measurement with a scintillation counter. Attachment and release profiles of FAs from the nanoconjugates are done using 3 H-labelled FAs ( 3 FA). The binding of 3 FA follows the order Au-PAM4-20K > Au-PAM2-10K > Au-PAM2-2K > Au > Au-PSH2-2K, whereas its release profile follows the reverse order. Au-PAM4-20K-FA has been used for folate receptor (FR)–mediated targeting of AuNPs to cancer cells. Seven different cancer cell lines (SKOV-3, OVCAR-5, OV-202, OV-167, OPM-1, RPMI, and U266) were screened for expression of FRs. Among ovarian cancer cells, the expression pattern of FRs follows the order OV-167 > SKOV-3 > OV-202 > OVCAR-5, and multiple myeloma cell lines follow the order OPM-1 > U266 > RPMI. Intracellular uptakes of the nanoconjugates containing FA or no FA were monitored with digital optical photography and TEM. Quantitation of the internalization of nanoconjugates in different cell lines was determined by gold analysis with inductively coupled plasma. It is found that the uptake of the nanoconjugates correlates with FR expression. Maximum uptake is observed for OV-167, whereas it is minimum for OVCAR-5. TEM images of the cells treated with Au-PAM4-20K-FA confirm the endocytosis of the nanoconjugates. This study is an important step for targeted delivery of anticancer drugs as well as metal nanoparticles for targeted therapy, tumor imaging, and ablation exploiting the overexpression of FRs on cancer cells.

[1]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  W. Faulk,et al.  Communication to the editors: An immunocolloid method for the electron microscope , 1971 .

[3]  P. Low,et al.  Evaluation of Folate Conjugate Uptake and Transport by the Choroid Plexus of Mice , 2003, Pharmaceutical Research.

[4]  B. Kamen,et al.  Receptor-mediated folate accumulation is regulated by the cellular folate content. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Mukhopadhyay,et al.  Assembly of Gold Nanoparticles in a Rod‐Like Fashion Using Proteins as Templates , 2006 .

[6]  R. Murray,et al.  Reactivity of Monolayer-Protected Gold Cluster Molecules: Steric Effects , 1998 .

[7]  S. Rothenberg,et al.  Purification, properties, and immunological characterization of folate-binding proteins from human leukemia cells. , 1987, Biochimica et biophysica acta.

[8]  P. Saigo,et al.  Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. , 1993, The American journal of pathology.

[9]  R. P. Andres,et al.  Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. , 2006, Bioconjugate chemistry.

[10]  A. Spurr.  A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.

[11]  Simon P Pricker.  Medical uses of gold compounds: Past, present and future , 1996 .

[12]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[13]  Ling Wang,et al.  Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.

[14]  G Toffoli,et al.  Overexpression of folate binding protein in ovarian cancers , 1997, International journal of cancer.

[15]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[16]  L. Bostad,et al.  High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein. , 1991, The Biochemical journal.

[17]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[18]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[19]  Vincent M Rotello,et al.  Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Satyajit Mayor,et al.  Folate receptor endocytosis and trafficking. , 2004, Advanced drug delivery reviews.

[21]  D. Richards,et al.  GOLD AND ITS RELATIONSHIP TO NEUROLOGICAL/GLANDULAR CONDITIONS , 2002, The International journal of neuroscience.

[22]  R. Kumar,et al.  Amphoterization of colloidal gold particles by capping with valine molecules and their phase transfer from water to toluene by electrostatic coordination with fatty amine molecules , 2000 .

[23]  M. Sastry,et al.  Electrostatic assembly of nanoparticles and biomacromolecules. , 2002, Accounts of Chemical Research.

[24]  J. Ross,et al.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.

[25]  B. Kamen,et al.  A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. , 2004, Advanced drug delivery reviews.

[26]  S. Mahdihassan.  Tan, cinnabar, as drug of longevity prior to alchemy. , 1984, The American journal of Chinese medicine.

[27]  Nathan Kohler,et al.  A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. , 2004, Journal of the American Chemical Society.

[28]  Jean-Marie Lehn,et al.  Comprehensive Supramolecular Chemistry , 1996 .

[29]  Xiaohua Huang,et al.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.

[30]  J. Onuchic,et al.  Mechanisms of protein assembly: lessons from minimalist models. , 2006, Accounts of chemical research.

[31]  J. Ross,et al.  Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. , 1994, Biochemistry.

[32]  Jean-Marie Lehn,et al.  Perspectives in Supramolecular Chemistry—From Molecular Recognition towards Molecular Information Processing and Self‐Organization , 1990 .

[33]  S. Rothenberg,et al.  Characterization of multiple forms of folate-binding protein from human leukemia cells. , 1986, Biochimica et biophysica acta.

[34]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[35]  M. D. de Villiers,et al.  Encapsulation of drug nanoparticles in self-assembled macromolecular nanoshells. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[36]  C. Shaw,et al.  Gold-Based Therapeutic Agents , 1999 .

[37]  T. Takahashi,et al.  Significant role of electrostatic interactions for stabilization of protein assemblies. , 1997, Advances in biophysics.

[38]  V. Zurawski,et al.  Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. , 1991, Cancer research.

[39]  A. Antony,et al.  The biological chemistry of folate receptors. , 1992, Blood.

[40]  D. Kranz,et al.  Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice , 1997, Journal of Neuro-Oncology.

[41]  D. Mukhopadhyay,et al.  Gold Nanoparticles do not Affect the Global Transcriptional Program of Human Umbilical Vein Endothelial Cells: A DNA-Microarray Analysis , 2005 .

[42]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[43]  K. Klein,et al.  Patterns of antigen distribution in human carcinomas. , 1990, Cancer research.

[44]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[45]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[46]  R. Murray,et al.  Monolayer-protected cluster molecules. , 2000, Accounts of chemical research.

[47]  James E. Hutchison,et al.  Monolayers in Three Dimensions: NMR, SAXS, Thermal, and Electron Hopping Studies of Alkanethiol Stabilized Gold Clusters , 1995 .

[48]  G. Higby,et al.  Gold in medicine , 1982, Gold bulletin.

[49]  V. Rotello,et al.  Controlled Assembly of Protein–Nanoparticle Composites through Protein Surface Recognition , 2005 .

[50]  Anthony Atala,et al.  Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells , 2004 .

[51]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[52]  Alexander M. Klibanov,et al.  Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Lehn,et al.  The design of cationic lipids for gene delivery. , 2005, Current pharmaceutical design.

[54]  George M. Whitesides,et al.  Formation of monolayers by the coadsorption of thiols on gold: variation in the head group, tail group, and solvent , 1989 .

[55]  Jean-Marie Lehn,et al.  Supramolecular chemistry — Scope and perspectives: Molecules — Supermolecules — Molecular devices , 1988 .

[56]  S. Weitman,et al.  The folate receptor in central nervous system malignancies of childhood , 2005, Journal of Neuro-Oncology.

[57]  J F Hainfeld,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.

[58]  Jean-Marie Lehn,et al.  Supramolecular Chemistry—Scope and Perspectives Molecules, Supermolecules, and Molecular Devices (Nobel Lecture) , 1988 .

[59]  D. Mukhopadhyay,et al.  Gold Nanoparticles Bearing Functional Anti-Cancer Drug and Anti-Angiogenic Agent: A "2 in 1" System with Potential Application in Cancer Therapeutics , 2005 .

[60]  S. Mahdihassan.  Cinnabar-gold as the best alchemical drug of longevity, called Makaradhwaja in India. , 1985, The American journal of Chinese medicine.

[61]  P Hobza,et al.  Noncovalent interactions: a challenge for experiment and theory. , 2000, Chemical reviews.

[62]  M. Sastry,et al.  Investigation into the Interaction between Surface-Bound Alkylamines and Gold Nanoparticles. , 2003, Langmuir : the ACS journal of surfaces and colloids.

[63]  Vincent M. Rotello,et al.  Fabrication and Self-Optimization of Multivalent Receptors on Nanoparticle Scaffolds , 2000 .

[64]  Xiaohua Huang,et al.  Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.

[65]  James R. Heath,et al.  Synthesis and Characterization of Hydrophobic, Organically-Soluble Gold Nanocrystals Functionalized with Primary Amines , 1996 .

[66]  V. Rotello,et al.  Engineering the nanoparticle-biomacromolecule interface. , 2006, Soft matter.

[67]  E. Dougherty,et al.  Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha). , 2003, International journal of oncology.

[68]  A. Ulman,et al.  Alkanethiol molecules containing an aromatic moiety self-assembled onto gold clusters , 1997 .